Matches in Wikidata for { <http://www.wikidata.org/entity/Q95393529> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- Q95393529 description "artículu científicu" @default.
- Q95393529 description "wetenschappelijk artikel" @default.
- Q95393529 description "наукова стаття" @default.
- Q95393529 name "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 name "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 type Item @default.
- Q95393529 label "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 label "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 prefLabel "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 prefLabel "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 P1433 Q95393529-81AB1EFE-08CE-448F-B1C7-3C5E1B68CF62 @default.
- Q95393529 P1476 Q95393529-3603B939-70C6-4DDF-AEE3-B715A896CE9F @default.
- Q95393529 P2093 Q95393529-106A7E0A-40DB-4A06-BC66-09BDB3D35D7A @default.
- Q95393529 P2093 Q95393529-6B160290-552D-4069-A1D6-5F11657E2D49 @default.
- Q95393529 P2093 Q95393529-71E0A891-DF97-42AE-920A-9862A7141F74 @default.
- Q95393529 P2093 Q95393529-826FB8ED-2C88-4015-8053-4509BBBAF5E8 @default.
- Q95393529 P2093 Q95393529-837868BB-A3AC-49D0-8C02-10CB847B53FB @default.
- Q95393529 P2093 Q95393529-83B7BAF3-3B35-4315-AB51-DC8A0C910F0D @default.
- Q95393529 P2093 Q95393529-8B4C98D2-FEBC-483A-8FB5-599A0409A958 @default.
- Q95393529 P2093 Q95393529-B379C8A1-7B3F-494C-8825-65EBB7CEA62C @default.
- Q95393529 P2093 Q95393529-C6559DEF-9B0C-4C22-9CF3-3CA6716802EB @default.
- Q95393529 P2093 Q95393529-CDDFE944-333A-43B8-99A5-12F5FEF0E8B5 @default.
- Q95393529 P2093 Q95393529-D5BFCB2D-8925-4415-9AC8-8974B2E03BB0 @default.
- Q95393529 P2093 Q95393529-DCC383E6-27D1-47D0-A48F-7F2E0E6ACA58 @default.
- Q95393529 P2093 Q95393529-EAC5D72A-C0E7-44DF-8D55-D72ED8C4FC4D @default.
- Q95393529 P2093 Q95393529-FBE83B37-951E-4E16-A65C-B77AA072DBCC @default.
- Q95393529 P2860 Q95393529-13F2322F-B92A-4849-92B3-9D111AF947BC @default.
- Q95393529 P2860 Q95393529-213E6715-1743-4578-84CD-2A9A99557129 @default.
- Q95393529 P2860 Q95393529-2B8738C1-BBB4-4DAE-A12B-B7F8DD2CFCC5 @default.
- Q95393529 P2860 Q95393529-4171731C-F34D-47E5-A35C-EC41A589E0A0 @default.
- Q95393529 P2860 Q95393529-4D16B34D-DD46-42E5-BBE9-4330EFF784D9 @default.
- Q95393529 P2860 Q95393529-675F91FB-A5D2-46D4-93ED-A4748E8B5E1C @default.
- Q95393529 P2860 Q95393529-B2D33C3E-46A4-4747-87DF-29BA06A6797E @default.
- Q95393529 P2860 Q95393529-D3B25383-C6AB-48E5-9E05-9D672939D71A @default.
- Q95393529 P2860 Q95393529-D6B24A2F-F92D-4B80-8558-56CB2E2854B9 @default.
- Q95393529 P2860 Q95393529-EB0E4C2C-BEC2-4893-9164-15BAB605D193 @default.
- Q95393529 P2860 Q95393529-F3F26217-A87F-4BAA-B302-317EFDCA0CFB @default.
- Q95393529 P2860 Q95393529-F4822AD1-711A-46A5-BF1D-951E2B0A521C @default.
- Q95393529 P304 Q95393529-69E27C53-0765-48E4-8804-90D630943B30 @default.
- Q95393529 P31 Q95393529-7D80DC93-B39A-423A-87CB-1FD1551FD721 @default.
- Q95393529 P356 Q95393529-6DC7CFB5-8AF2-4A0F-B9A5-2723B5CD2F99 @default.
- Q95393529 P433 Q95393529-0EBE7565-822D-4A8D-AA96-F281D9FA72A9 @default.
- Q95393529 P478 Q95393529-A696F000-FCBC-471C-9633-F2D51B11F8F5 @default.
- Q95393529 P50 Q95393529-E8AF046B-F055-46AE-BB17-F3EC7CA7A5D7 @default.
- Q95393529 P577 Q95393529-3318BD55-D94E-4BFC-B6FA-36CA3E13A4A7 @default.
- Q95393529 P698 Q95393529-31B2ECAA-177E-415C-A2DB-679B68400055 @default.
- Q95393529 P921 Q95393529-4533A7F3-7D7F-42C1-9C2F-D53C528B92FD @default.
- Q95393529 P921 Q95393529-ACA805F3-D827-4F73-A8AB-FD881FFB98E2 @default.
- Q95393529 P932 Q95393529-416C99B6-B2F7-4260-9623-9B19A53CFFEC @default.
- Q95393529 P356 DKY564 @default.
- Q95393529 P698 30668695 @default.
- Q95393529 P1433 Q6294770 @default.
- Q95393529 P1476 "Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353" @default.
- Q95393529 P2093 "ACTG A5353 Study Team" @default.
- Q95393529 P2093 "Amesika N Nyaku" @default.
- Q95393529 P2093 "Babafemi O Taiwo" @default.
- Q95393529 P2093 "Baiba Berzins" @default.
- Q95393529 P2093 "Beverly E Sha" @default.
- Q95393529 P2093 "Carole L Wallis" @default.
- Q95393529 P2093 "Catherine Godfrey" @default.
- Q95393529 P2093 "Cornelius N Van Dam" @default.
- Q95393529 P2093 "David W Haas" @default.
- Q95393529 P2093 "Edward P Acosta" @default.
- Q95393529 P2093 "Kimberly Y Smith" @default.
- Q95393529 P2093 "Lu Zheng" @default.
- Q95393529 P2093 "Maxine Olefsky" @default.
- Q95393529 P2093 "Roy M Gulick" @default.
- Q95393529 P2860 Q28269931 @default.
- Q95393529 P2860 Q34413527 @default.
- Q95393529 P2860 Q38376451 @default.
- Q95393529 P2860 Q39498339 @default.
- Q95393529 P2860 Q39570904 @default.
- Q95393529 P2860 Q40059796 @default.
- Q95393529 P2860 Q40059801 @default.
- Q95393529 P2860 Q41752733 @default.
- Q95393529 P2860 Q43300648 @default.
- Q95393529 P2860 Q45910955 @default.
- Q95393529 P2860 Q47290558 @default.
- Q95393529 P2860 Q93013683 @default.
- Q95393529 P304 "1376-1380" @default.
- Q95393529 P31 Q13442814 @default.
- Q95393529 P356 "10.1093/JAC/DKY564" @default.
- Q95393529 P433 "5" @default.
- Q95393529 P478 "74" @default.
- Q95393529 P50 Q91303052 @default.
- Q95393529 P577 "2019-05-01T00:00:00Z" @default.
- Q95393529 P698 "30668695" @default.
- Q95393529 P921 Q422631 @default.
- Q95393529 P921 Q937224 @default.
- Q95393529 P932 "6477973" @default.